To define a new approach for treatment of neovascular ARMD cases with less frequent visits and injections.


Neovascular ARMD cases that have been followed-up for 1-2 year period were analyzed retrospectively and those who had regular intervals of recurrence were identified. An individualized visit and injection period was defined for each of those patients separately.


Those cases that had regular intervals of activation will need less visits and will be treated just before the next expected activation so that a new attack would not damage the fovea further.

Take Home message:

A tailored approach for each individual neovascular ARMD case will save time and money while preserving the macula from further damage.